Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT00134433
Eligibility Criteria:
Inclusion Criteria:
* Severe chronic angina
* Multi-vessel coronary artery disease
* Diffusely diseased left anterior descending coronary artery (LAD)
* At least 18 years of age at the time of written informed consent
Exclusion Criteria:
* Pregnancy, lactation, or any child-bearing potential
* Patients who are candidates for percutaneous transluminal coronary angioplasty (PTCA) or stenting
* Severe left ventricular dysfunction (ejection fraction \< 30%)
* Threatened proximal coronary occlusion or unstable angina
* Recent myocardial infarction (\< 1 month)
* Chronic renal failure (serum creatinine \> 130 µmol/L)
* Hepatic insufficiency (Child-Pugh Class C)
* Clinically significant valvular heart disease
* Personal history of neoplasia
* Abnormal serum prostate-specific antigen (PSA), bowel neoplasia screening questionnaire, or updated mammography report (if female) - any test not performed within the last 6 months will be conducted prior to confirmation of eligibility
* Family history of cancer (i.e. ≥ 2 first-degree relatives)
* History of diabetic retinopathy
* Latent herpes infection
* Schizophrenia
* Claustrophobia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00134433
Study Brief:
Protocol Section:
NCT00134433